Skip to main content

Table 2 Peri-operative outcomes

From: Metformin is not associated with lactic acidosis in patients with diabetes undergoing coronary artery bypass graft surgery: a case control study

 

Group I Diabetes + Metformin n = 41 (32%)

Group II Diabetes - Metformin n = 86 (68%)

P-value

Ventilation time (hours) ± SD

8.0 ± 15.0

8.0 ± 9.2

0.998

Intensive care time (hours) ± SD

42.8 ± 33.7

46.1 ± 45.4

0.692

Cardiopulmonary bypass time (minutes) ± SD

103.5 ± 32.3

100.8 ± 38.9

0.709

Cross clamp time (minutes) ± SD

83.2 ± 31.3

79.8 ± 32.3

0.590

Post-op cardiac index (mean) ± SD

3.0 ± 0.5

2.9 ± 0.5

0.277

Lowest mixed venous oxygen saturation % (SVO2)

55.8 ± 6.4

55.9 ± 8.6

0.950

Number of vasopressors >1

5 (12.2%)

24 (27.9%)

0.049

Intra-aortic balloon pump (%)

2 (4.9%)

8 (9.3%)

0.498

Myocardial infarction (%)

1 (2.4%)

6 (7.0%)

0.427

Low output syndrome (%)

7 (17.1%)

21 (24.4%)

0.351

New post-op dialysis (%)

0 (0%)

1 (1.2%)

1.000

Atrial Fibrillation (%)

0 (0%)

7 (8.1%)

0.095

Pulmonary complications (%)

7 (17.1%)

19 (22.1%)

0.640

Stroke/Transient ischemic attack (%)

1 (2.4%)

3 (3.5%)

1.000

Surgical site infection (%)

2 (4.9%)

7 (8.1%)

0.717

Death (%)

0 (0%)

2 (2.3%)

1.000